Corline Biomedical AB (CLBIO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Corline Biomedical AB (CLBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11470
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Corline Biomedical AB (Corline Biomedical), formerly Corline Systems AB is a manufacturer of heparin based solutions. The company offers heparin based solutions to improve kidney transplantation, and applications in the field of regenerative medicine. Its regentrative medicines include cytoparin for cell therapy and diabetes type 1, and renaparin for kidney transplantation. Corline Biomedical offers CHC based on pre-assembled aggregates of heparin molecules. The company also provides surface coatings. It partners with medical device companies to improve blood and biocompatibility of medical device implants. Corline Biomedical is headquartered in Uppsala, Sweden.

Corline Biomedical AB (CLBIO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corline Biomedical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Corline Biomedical to Enter into Agreement with University of Alberta 10
Corline Biomedical to Enter into Agreement with Nuffield Department of Surgical Sciences 11
Equity Offering 12
Corline Biomedical Raises USD1.31 Million in Rights Offering of Shares 12
Corline Biomedical Raises USD1.88 Million in Rights offering of Shares 13
Corline Biomedical Raises USD3 Million in Rights offering of Shares 15
Corline Biomedical Raises USD8.73 Million in Initial Public Offering of Shares 16
Corline Biomedical AB – Key Competitors 17
Corline Biomedical AB – Key Employees 18
Corline Biomedical AB – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Aug 23, 2018: Corline Biomedical publishes interim report for the first half of 2018 20
May 17, 2018: Corline Biomedical publishes interim report for the first quarter of 2018 22
Feb 22, 2018: Corline Biomedical publishes the year-end report for 2017 23
Nov 16, 2017: Corline Biomedical publishes the interim report for January – September 2017 25
Aug 23, 2017: Corline Biomedical: Announces interim report for the period January – June 2017 27
May 18, 2017: Corline Biomedical publishes the interim report for January to March 2017 29
Feb 23, 2017: Corline Biomedical publishes year-end report for January – December 2016 30
Corporate Communications 31
Apr 03, 2017: Corline Biomedical: Further expertise and networking is provided to the Board 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Corline Biomedical AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corline Biomedical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corline Biomedical AB, Deals By Therapy Area, 2012 to YTD 2018 8
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Corline Biomedical to Enter into Agreement with University of Alberta 10
Corline Biomedical to Enter into Agreement with Nuffield Department of Surgical Sciences 11
Corline Biomedical Raises USD1.31 Million in Rights Offering of Shares 12
Corline Biomedical Raises USD1.88 Million in Rights offering of Shares 13
Corline Biomedical Raises USD3 Million in Rights offering of Shares 15
Corline Biomedical Raises USD8.73 Million in Initial Public Offering of Shares 16
Corline Biomedical AB, Key Competitors 17
Corline Biomedical AB, Key Employees 18

List of Figures
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Corline Biomedical AB (CLBIO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bio-Path Holdings Inc (BPTH):医療機器:M&Aディール及び事業提携情報
    Summary Bio-Path Holdings Inc (Bio-Path) is a clinical stage biotechnology company that develops targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers. The company provides products pipeline such as prexigebersen (Liposomal Grb2 Antisense) …
  • Watt’s S.A.:企業の戦略・SWOT・財務情報
    Watt's S.A. - Strategy, SWOT and Corporate Finance Report Summary Watt's S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Endress+Hauser AG:企業の戦略的SWOT分析
    Endress+Hauser AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Nizhnekamskneftekhim (NKNC):企業の財務・戦略的SWOT分析
    Nizhnekamskneftekhim (NKNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Stamford Land Corporation Ltd:企業の戦略・SWOT・財務情報
    Stamford Land Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Stamford Land Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • XALT Energy LLC:企業の戦略的SWOT分析
    XALT Energy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Castle Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Castle Biosciences Inc (Castle Biosciences) is a drug development company that develops and commercializes diagnostic and prognostic tests for cancers. The company offers tests for cutaneous melanoma, uveal melanoma and glioblastoma multiforme. Its DecisionDx-melanoma identifies stage I or I …
  • The Tata Power Company Limited:企業の戦略・SWOT・財務分析
    The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Helius Medical Technologies Inc (HSM):製品パイプライン分析
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that offers neurological wellness solutions. The company offers development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It offers development of technolog …
  • Zoll Medical Corporation-医療機器分野:企業M&A・提携分析
    Summary ZOLL Medical Corporation (Zoll), a subsidiary of Asahi Kasei Corporation, is a provider of medical devices and software solutions for advance emergency care. The company designs, manufactures and markets resuscitation devices and systems used for resuscitation and acute critical care victims …
  • PanAtlantic Exploration Co:企業の戦略的SWOT分析
    PanAtlantic Exploration Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Rexnord Corp (RXN):電力:M&Aディール及び事業提携情報
    Summary Rexnord Corp (Rexnord) offers process and motion control, and water management products. The company designs, manufactures, markets and services mechanical components, and water flow control and conservation products. Its product portfolio includes motion control products, aerospace componen …
  • Statnett SF:電力:M&Aディール及び事業提携情報
    Summary Statnett SF (Statnett) transmits and distributes high voltage electricity in Norway primarily generated from its hydro-electric power plants. It operates as a system operator in the Norwegian energy system. The company is a state enterprise, established under the Act relating to state-owned …
  • Banyan Biomarkers Inc:企業の製品パイプライン分析2018
    Summary Banyan Biomarkers Inc (Banyan Biomarkers) is a medical technology company that commercializes vitro diagnostic tests for the detection of traumatic brain injury and neurological diseases. The company’s product pipeline includes biomarkers for depression, hypoxic ischemic encephalopathy, neur …
  • Kurabo Industries Ltd (3106):企業の財務・戦略的SWOT分析
    Kurabo Industries Ltd (3106) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • curasan AG (CUR):企業の製品パイプライン分析2018
    Summary curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, ora …
  • Snap-on Inc (SNA):企業の財務・戦略的SWOT分析
    Snap-on Inc (SNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Avingtrans Plc (AVG):企業の財務・戦略的SWOT分析
    Avingtrans Plc (AVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bioverativ Inc (BIVV):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technolog …
  • KPIT Technologies Ltd (KPIT):企業の財務・戦略的SWOT分析
    KPIT Technologies Ltd (KPIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆